Organizations sign five-year extension to their R&D engagement, including an expansion of the Applied Materials–Institute of Microelectronics Center of Excellence in Advanced Packaging in Singapore New phase of research aims to accelerate breakthroughs in materials, equipment and process technologies for hybrid bonding and other emerging, 3D chip integration technologies Expansion provides semiconductor and systems companies…
Huntkey to Release GaN Chargers
Huntkey to Release GaN Chargers
SHENZHEN, CHINA – Media OutReach – 15 December 2020 – Huntkey, a leading provider of power solutions, has recently announced that it is going to release its 65W GaN charger(shortened as “the charger” below) for global markets.
The charger features two charging ports – one USB-C port and one USB-A port. The USB-C port is designed for fast charging speed, independently, it can output 5V3A, 9V3A, 12V3A, 15V3A or 20V3.25A, 65W at the maximum. The USB-A port can output 5V3A or 9V3A, 27W at the maximum.
When simultaneously charging devices, two ports combined will support a total power output of 57W, 45W (20V2.25A) of which is from the USB-C port and 12W(5V2.4A) is from the USB-A port. According to lab testing, the charger is able to fully charge a MacBook within 1.5 hours and half charge an iPhone 12 within 30 minutes.
News Category Global Banking & Finance Reviews
ALX Oncology Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
ALX Oncology Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
BURLINGAME, Calif., Dec. 14, 2020 ALX Oncology Holdings Inc. (“ALX Oncology”) (Nasdaq: ALXO), a clinical-stage immuno-oncology company developing therapies to block the CD47 checkpoint pathway, today announced the closing of its previously announced underwritten public offering of 2,737,000 shares of its common stock, which includes the exercise in full of the underwriters’ option to purchase 357,000 additional shares of its common stock, at a price to the public of $76.00 per share. The aggregate gross proceeds to ALX Oncology from the offering were approximately $208.0 million, before deducting underwriting discounts and commissions and other offering expenses. All of the s
LPL Financial Hires Brent Simonich as EVP, Chief Accounting Officer and Treasurer
LPL Financial Hires Brent Simonich as EVP, Chief Accounting Officer and Treasurer
CHARLOTTE, N.C., Dec. 14, 2020 LPL Financial LLC, a leading retail investment advisory firm, registered investment advisor (RIA) custodian and independent broker-dealer, today announced that Brent Simonich has joined the firm as executive vice president, chief accounting officer and treasurer, effective today. In this role, Simonich will be responsible for shaping the forward-looking strategy, business objectives and corporate goals for LPL’s Controllership, Treasury and Procurement functions. He is based at the firm’s Carolinas campus and reports to Matt Audette, LPL managing director and chief financial officer.